Epcoritamab with rituximab + lenalidomide (R(2)) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7 Meeting Abstract
| Authors: | Lori, L. A.; Falchi, L.; Vermaat, J. S. P.; Musuraca, G.; Belada, D.; Nijland, M.; Christensen, J. H.; Offner, F.; Hoehn, D.; Marek, J.; Wang, L. W.; Mei, J. P.; Abrisqueta, P.; Brody, J. D. |
| Abstract Title: | Epcoritamab with rituximab + lenalidomide (R(2)) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7 |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401664 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.7014 |
| Notes: | Meeting Abstract: 7014 -- Source: Wos |
